Roivant Sciences Ltd. (ROIV) Q2 2025 Earnings Name November 10, 2025 8:00 AM EST
Firm Members
Stephanie Lee Griffin – Chief Working Officer of Roivant Platforms
Matthew Gline – CEO & Director
Convention Name Members
David Risinger – Leerink Companions LLC, Analysis Division
Lut Ming Cheng – JPMorgan Chase & Co, Analysis Division
Samantha Semenkow – Citigroup Inc., Analysis Division
Yaron Werber – TD Cowen, Analysis Division
Prakhar Agrawal – Cantor Fitzgerald & Co., Analysis Division
Corinne Jenkins – Goldman Sachs Group, Inc., Analysis Division
Yuchen Ding – Jefferies LLC, Analysis Division
Dominic Risso-Gill
Douglas Tsao – H.C. Wainwright & Co, LLC, Analysis Division
Hao Shen – Wells Fargo Securities, LLC, Analysis Division
Thomas Smith – Leerink Companions LLC, Analysis Division
Brandon Frith – Wolfe Analysis, LLC
Gaurav Maini – LifeSci Capital, LLC, Analysis Division
Presentation
Operator
Good day, and thanks for standing by. Welcome to the Roivant’s Second Quarter 2025 Earnings Name.
[Operator Instructions] Please notice that immediately’s convention is being recorded. I’ll now hand the convention over to your first speaker Stephanie Lee. Chances are you’ll start.
Stephanie Lee Griffin
Chief Working Officer of Roivant Platforms
Good morning, and thanks for becoming a member of immediately’s name to assessment Roivant’s monetary outcomes for the second quarter ended September 30, 2025. I am Stephanie Lee with Roivant.
Presenting immediately, we’ve got Matt Gline, CEO of Roivant. For these dialing in through convention name, you could find the slides being offered immediately in addition to the press launch saying these updates on our IR web site at www.investor.roivant.com. We’ll even be offering the present slide numbers as we current that can assist you observe alongside.
I would prefer to remind you that we’ll be making sure forward-looking statements throughout immediately’s presentation. We strongly encourage you to assessment the knowledge that we filed with the SEC for extra info relating to these forward-looking statements and associated dangers and uncertainties.
